Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD11B1 | P28845 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13390625 | 0.85 | MEN1 (0.41) | MEN1KMT2AALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL7859286 | 0.83 | HSD11B1 (0.58) | HSD11B1MEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL7046134 | 0.83 | HSD11B1 (0.58) | HSD11B1MEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL9875732 | 0.81 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL9875280 | 0.81 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL9875282 | 0.81 | ALDH1A1 (0.46) | MEN1KMT2AALDH1A1CYP1A2CYP2C9 | |
| SCHEMBL1066268 | 0.81 | TSHR (0.42) | MEN1KMT2ACYP2C9CYP2C19TSHR | |
| SCHEMBL17317476 | 0.79 | CHRNB2 (0.52) | HSD11B1MEN1KMT2AALDH1A1CYP1A2 | |
| SCHEMBL10248813 | 0.74 | BRD4 (0.44) | HSD11B1ALDH1A1TSHR | |
| SCHEMBL5639352 | 0.74 | SLC6A12 (0.46) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9353213-B2 | Functional norbornanyl ester derivatives, polymers and process for preparing same | YU HUI (US) | 2016-05-31 | — | — | US | disclosed |
| US-20160122469-A1 | Functional norbornanyl ester derivatives, polymers and process for preparing same | YU HUI (US) | 2016-05-05 | — | — | US | disclosed |
| US-8883897-B2 | Functional norbornanyl ester derivatives, polymers and process for preparing same | New Functional Polymers LLC (US) | 2014-11-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122469-A1 | Functional norbornanyl ester derivatives, polymers and process for preparing same | CYP1B1, DECR1, CAD | HSD11B1 149/4885MEN1 2776/4885KMT2A 2354/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.